Literature DB >> 26424951

Heart transplantation in the Ehlers-Danlos syndrome.

Stephanie M Reinhold1, Brian Lima1, Adnan Khalid1, Gonzalo V Gonzalez-Stawinski1, Robert C Stoler1, Shelley A Hall1, Themistokles Chamogeorgakis1.   

Abstract

We describe a woman with Ehlers-Danlos syndrome and aortic aneurysm who experienced a myocardial infarction due to spontaneous left circumflex coronary artery dissection 3 weeks postpartum. She developed end-stage heart failure and subsequently underwent a successful orthotopic heart transplantation. To our knowledge, this is the first report of a heart transplant performed in an individual with Ehlers-Danlos syndrome.

Entities:  

Year:  2015        PMID： 26424951      PMCID： PMC4569234          DOI： 10.1080/08998280.2015.11929319

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  9 in total

1.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.

Authors:  Loren F Hiratzka; George L Bakris; Joshua A Beckman; Robert M Bersin; Vincent F Carr; Donald E Casey; Kim A Eagle; Luke K Hermann; Eric M Isselbacher; Ella A Kazerooni; Nicholas T Kouchoukos; Bruce W Lytle; Dianna M Milewicz; David L Reich; Souvik Sen; Julie A Shinn; Lars G Svensson; David M Williams
Journal:  Circulation       Date:  2010-03-16       Impact factor: 29.690

2.  Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.

Authors:  M Pepin; U Schwarze; A Superti-Furga; P H Byers
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

3.  Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.

Authors:  Sherene Shalhub; James H Black; Alana C Cecchi; Zhi Xu; Ben F Griswold; Hazim J Safi; Dianna M Milewicz; Nazli B McDonnell
Journal:  J Vasc Surg       Date:  2014-03-18       Impact factor: 4.268

4.  COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture.

Authors:  F M Pope; P Narcisi; A C Nicholls; D Germaine; G Pals; A J Richards
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

5.  Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).

Authors:  P Beighton; A De Paepe; B Steinmann; P Tsipouras; R J Wenstrup
Journal:  Am J Med Genet       Date:  1998-04-28

6.  The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience.

Authors:  Gustavo S Oderich; Jean M Panneton; Thomas C Bower; Noralane M Lindor; Kenneth J Cherry; Audra A Noel; Manju Kalra; Timothy Sullivan; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2005-07       Impact factor: 4.268

7.  Histopathologic findings in human aortic media associated with pregnancy.

Authors:  P Manalo-Estrella; A E Barker
Journal:  Arch Pathol       Date:  1967-04

Review 8.  Contemporary management of vascular Ehlers-Danlos syndrome.

Authors:  Ying Wei Lum; Benjamin S Brooke; James H Black
Journal:  Curr Opin Cardiol       Date:  2011-11       Impact factor: 2.161

9.  Maternal hemodynamics and aortic diameter in normal and hypertensive pregnancies.

Authors:  T R Easterling; T J Benedetti; B C Schmucker; K Carlson; S P Millard
Journal:  Obstet Gynecol       Date:  1991-12       Impact factor: 7.661
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.